Home AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
 

Keywords :   


AbbVie to buy leukemia drugmaker Pharmacyclics for $21B

2015-03-06 06:29:46| Food - Topix.net

AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug. The deal will give the North Chicago, Ill., drugmaker Imbruvica, a blood cancer treatment that Pharmacyclics makes and then markets with Johnson & Johnson's Janssen Biotech.

Tags: buy leukemia 21b drugmaker

Category:Food and Related Products

Latest from this category

All news

»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »